OMMA Advisory Council Meeting: April 17, 2026
Public commenters pressed the Oklahoma Medical Marijuana Authority on testing transparency, alleged THC potency inflation and recall practices; OMMA executives described QA lab progress, compliance activity and pending legislation; no votes were taken for lack of quorum.
AI-Generated Content
The text on this page is AI generated. Summaries, highlights, analysis, and video transcripts are all produced from the original source material.
AI can make mistakes, so if you spot one, and we will fix it for everyone.
Note: the source content is unaltered by us. Any content source we link to, be it a video, an audio recording, or a document, is presented exactly as its publisher released it. That publisher is usually a government body, sometimes an individual official or another organisation.
No transcript available.
